"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
| Descriptor ID |
D000328
|
| MeSH Number(s) |
M01.060.116
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 46 | 46 |
| 1996 | 0 | 53 | 53 |
| 1997 | 0 | 63 | 63 |
| 1998 | 0 | 66 | 66 |
| 1999 | 0 | 50 | 50 |
| 2000 | 0 | 64 | 64 |
| 2001 | 0 | 73 | 73 |
| 2002 | 0 | 103 | 103 |
| 2003 | 0 | 104 | 104 |
| 2004 | 0 | 129 | 129 |
| 2005 | 0 | 130 | 130 |
| 2006 | 0 | 154 | 154 |
| 2007 | 0 | 166 | 166 |
| 2008 | 0 | 169 | 169 |
| 2009 | 0 | 192 | 192 |
| 2010 | 0 | 199 | 199 |
| 2011 | 0 | 225 | 225 |
| 2012 | 0 | 255 | 255 |
| 2013 | 0 | 280 | 280 |
| 2014 | 0 | 285 | 285 |
| 2015 | 0 | 339 | 339 |
| 2016 | 0 | 359 | 359 |
| 2017 | 0 | 391 | 391 |
| 2018 | 0 | 304 | 304 |
| 2019 | 0 | 358 | 358 |
| 2020 | 0 | 307 | 307 |
| 2021 | 0 | 274 | 274 |
| 2022 | 0 | 113 | 113 |
| 2023 | 0 | 51 | 51 |
| 2024 | 0 | 154 | 154 |
| 2025 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
Depression and Incident Hypertension: The Strong Heart Family Study. Prev Chronic Dis. 2025 Jan 16; 22:E06.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
Cannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adults. Subst Abuse Treat Prev Policy. 2025 Jan 11; 20(1):1.
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
-
18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiol Imaging Cancer. 2025 Jan; 7(1):e240096.
-
Impact of Medical Improvisation on Therapeutic Use of Self: A Randomized Controlled Waitlist Study. Am J Occup Ther. 2025 Jan 01; 79(1).
-
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Cancer. 2025 Jan 01; 131(1):e35680.
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
-
Impacts of the US CDC recommendation on human papillomavirus vaccine uptake, 2010-2015. Front Public Health. 2024; 12:1464685.